Text and Data Mining valid from 2019-02-01
First Online: 11 February 2019
Compliance With Ethical Standards
: John Esther declares that he has no conflict of interest.Benjamin L. Maughan has received compensation from Janssen Oncology, Exelixis, Peloton Therapeutics, and Tempus for participation on advisory boards.Neysi Anderson declares that she has no conflict of interest.Neeraj Agarwal has received research funding (paid to his institution) from Active Biotech, AstraZeneca, Bavarian Nordic, Bristol-Myers Squibb, Calithera, Celldex, Eisai, Exelixis, Genentech, GlaxoSmithKline, Immunomedics, Janssen, Medivation, Merck, NewLink Genetics, Novartis, Pfizer, Prometheus, Rexahn, Sanofi, Takeda, and TRACON Pharmaceuticals; and has received compensation from Pfizer, Novartis, Merck, Genentech, Eisai, Exelixis, Clovis, EMD Serono, Bristol-Myers Squibb, AstraZeneca, FoundationOne, Astellas, Eli Lilly, Bayer, Argos, Medivation, and Nektar for service as a consultant.Andrew W. Hahn declares that he has no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.